Cat.No. |
Chemical Name |
MolFormula |
HR472572 |
Octahydro-2,6-dimethyl-3,8:4,7-dimethano-2,6-naphthyridine-4,8-dimethanol |
C14H24N2O2 |
HR472552 |
O-(N-Biotiny-NH-(PEG)2-COOH·DIPEA |
C33H63N5O8S |
HR472476 |
Octahydrocyclopenta[b][1,4]oxazine |
C7H13NO |
HR472467 |
Octahydrofuro[3,2-c]pyridine hydrochloride |
C7H14ClNO |
HR472380 |
Octahydrocyclopenta[c]pyrrol-4-ol |
C7H13NO |
HR472306 |
Octamethyleneimine |
C8H17N |
HR472256 |
Octahydro-1H-pyrido[1,2-a]pyrazine dihydrochloride |
C8H18Cl2N2 |
HR469836 |
Oclacitinib |
C19H27N5O6S |
HR469762 |
OTSSP167 hydrochloride |
C25H29Cl3N4O2 |
HR469603 |
On 146040 |
C24H23N7O3S |
HR469593 |
Oleonuezhenide |
C48H64O27 |
HR469510 |
Osteogenicgrowthpeptide |
C68H110N22O18 |
HR469478 |
ORL1 Antagonist 1 |
C20H22ClN5 |
HR469467 |
OT Antagonist 3 |
C21H20N6O2 |
HR469260 |
Oxazosulfyl |
C15H11F3N2O5S2 |
HR469058 |
Op-0595 |
C9H16N4O7S |
HR468660 |
Oleicanhydride |
C36H66O3 |
HR466413 |
Oxonane-2,9-dione |
C8H12O3 |
HR458985 |
Octyl 2-chloroisonicotinate |
C14H20ClNO2 |
HR456500 |
O-5-Bromopyridin-3-yl dimethylcarbamothioate |
C8H9BrN2OS |
HR454129 |
O-Ethyl di(piperazin-1-yl)phosphinothioate |
C10H23N4OPS |
HR454060 |
O-(4-Aminophenyl) O,O-diethyl phosphorothioate |
C10H16NO3PS |
HR453207 |
O-(tert-Butyldiphenylsilyl)hydroxylamine |
C16H21NOSi |
HR451027 |
Octyl 4-methylbenzenesulfonate |
C15H24O3S |
HR450129 |
O-((6-(1H-Pyrazol-1-yl)pyridin-3-yl)methyl)hydroxylamine |
C9H10N4O |
HR449893 |
O,O'-(Ethane-1,2-diyl)bis(hydroxylamine) dihydrochloride |
C2H10Cl2N2O2 |
HR445815 |
Octadec-9-yne |
C18H34 |
HR445517 |
O-(Prop-2-yn-1-yl)hydroxylamine hydrochloride |
C3H6ClNO |
HR445472 |
Oct-2-ynoic acid |
C8H12O2 |
HR444000 |
Octahydro-1H-pyrrolo[3,4-b]pyridine |
C7H14N2 |